TotalMarketCap

Imunon

IMNNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.859 M

$0.87 -4.52%

Close of 6 Nov 2026

As of 6 Nov 2026, Imunon (IMNN) has a market capitalization of $4.86M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$14.5M

#1960 by earnings

Shares outstanding

5,611,403

Latest filing cover page

P/E ratio

0.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #450ScientureSCNX$5.18M
  2. #451GelteqGELS$4.88M
  3. #452ImunonIMNN$4.86M
  4. #453Addex TherapeuticsADXN$4.86M
  5. #454Can-Fite BioPharmaCANF$4.85M

What if Imunon were worth as much as…

Open the what-if tool →

Gold $28.2T

$5,032,052

Per share 5,810,684× higher

Bitcoin $1.53T

$272,275.59

Per share 314,406× higher

Apple $5.02T

$893,855.35

Per share 1,032,166× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Imunon are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.